Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Fulcrum Therapeutics, Inc. Common Stock | FULC

AI Analysis of Fulcrum Therapeutics, Inc. Common Stock

Fulcrum Therapeutics hasn't moved too much today but is slightly up, only up 0.81% since yesterday.

Fulcrum Therapeutics doesn't seem to be at a very clear reversal point in either direction. Fulcrum Therapeutics hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. FULC might find some support at the 12.48 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Companies with the highest correlation to Fulcrum Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
RNA | Avidity Biosciences, Inc.0.54-0.810.500.08-6.02-83.30-73.4236-441.04-16.52-52.62-133539.00-420.18010011.8771
TXG | 10x Genomics, Inc. Class 0.39-1.2526.6429.83169.23201.57350.8266133.7866.8583.580.00-21945.04008.00406

Top 3 correlating companies

See full charts for all peers

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-